Apollo was co-founded in 2017 by Kathryn Fantauzzi and her husband, Dr. David Rabin, MD, PhD.

Dedicated to innovation, Kathryn believes in getting good science out of the lab - and into people’s lives. Experienced in early-stage tech commercialization, Kathryn joined the University of Pittsburgh research team in 2016 to raise funding for clinical research on the Apollo discovery. As CEO, Kathryn has built a highly-skilled collaboration of physicians, researchers, engineers, and designers to transform the Apollo technology from a futuristic concept into a simple but powerful tool.

Dr. David Rabin, MD, PhD, is a neuroscientist, board-certified psychiatrist, health tech entrepreneur and inventor who has been studying the impact of chronic stress in humans for more than a decade. He is the co-founder & chief medical officer at Apollo Neuroscience, which has developed the first scientifically-validated wearable technology that actively improves energy, focus & relaxation, using a novel touch therapy that signals safety to the brain. In addition to his clinical psychiatry practice, Dr. Rabin is currently conducting research on the epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic-assisted psychotherapy and the neurobiology of belief.